The life sciences industry is in the midst of a transformation, bringing both opportunities and challenges.
Increased healthcare consumption by aging populations in developed countries and a growing middle class in emerging markets, along with the rapid pace of scientific and technological breakthroughs, suggest a bright future for the industry. However, complications arise from shifting healthcare profit pools driven by demand for better health outcomes, increasing digital disruption in the healthcare ecosystem, and a more engaged and educated healthcare consumer. Therefore, companies need to consider new strategies, business models, processes and innovative ways of using data. At CSC, we continually engage with various stakeholders to help our clients navigate the changing environment. Our life sciences strategy is based on a fundamental assumption that digital technologies and services present disruptive opportunities for life sciences companies to thrive in an emerging digital healthcare ecosystem. This strategy recognizes the significant shift from product to consumer as the market driver.
CSC has developed a progressive digital solution platform approach for driving agile and capital-efficient innovation across the value chain.CSC’s Capital-Efficient Innovation strategy helps you focus on key areas of immediate need and the most significant opportunities by driving transformation that improves risk management, agility and cost-efficiency.
Life sciences companies are under pressure to balance innovation with cost-cutting measures — across the enterprise — while ensuring that the drugs they bring to market are managed in a patient-centric way. The flow of information from research and development (R&D) to the health authority, and then from the affiliate ultimately to the patient, requires a new regulatory information management (RIM) plan.
With the complex dynamics in play, life sciences companies must adopt a big-picture RIM strategy that drives smarter, faster and lower-cost decision making. The end goal for the life sciences enterprise of the future is an intelligent, interconnected RIM framework that rethinks and recasts the core set of regulatory systems
CSC’s Digital RIM solution is an industry-leading regulatory blueprint that combines CSC’s life sciences expertise, software and services, leading industry technology solutions, and best-of-breed partner solutions. The solution offers a catalyst for change that enables clients to derive business value beyond compliance. Through CSC’s Digital RIM solution, clients are well-positioned to leverage information across the enterprise and share data with partners securely, without risking compliance missteps..
R&D productivity is an increasingly competitive challenge. Companies are racing to tap the power and potential of the genome to provide physicians and patients with solutions that meet growing demands for predictive medicine, personalized medicine and personalized care.
Life sciences companies are embracing new R&D modes of development. They are embracing more collaborative R&D approaches, working with other companies, partners and institutions to optimize their R&D investment, accelerate new insights and achieve new breakthroughs. This kind of collaboration can be facilitated by a secure, rules-based access R&D application infrastructure.
We develop a secure R&D application infrastructure with the appropriate utilization elasticity for your specific needs; rules-based access; and information insights enabled by advanced cloud computing and orchestration, cybersecurity, and big data and analytics platforms.
Next-Generation Supply Chain
Increasingly, the life sciences companies are stakeholders in the overall healthcare ecosystem, going beyond the development of products to the enablement of care. For life sciences organizations, delivering products to customers in a timely and accurate manner is a must.
The next-generation digital supply chain is about the smooth management of products across the value chain. It goes a long way toward controlling inventory, improving work processes, adapting to shifts in the provision of care models and protecting brandsIt comprises multiple distribution channels in multiple regions and with multiple collaborative partners, and it’s now integral to the overall business fabric and success of life sciences companies.
Our supply chain solutions can help you transition from a stock-based model to an order-based model that is more flexible, reliable, responsive, transparent and secure.
The commercial environment in the life sciences industry has to transform itself to meet the rapid pace of digitization — from leveraging the Internet to engage in dialogues with product users, to gathering and monitoring information from physicians, patients and key opinion leaders, to rapidly repurposing commercial documents as new information emerges. CSC offers a digital transformation methodology that helps to drive out cost- and resource-intensive activities — such as manual intervention and large sales forces — and builds value through customer outreach and engagement, the ability to repurpose materials, and the opening of new market opportunities.
CSC’s commercial digitization solutions help companies respond to complex market dynamics. For example, through mobility and analytics offerings, CSC helps clients adapt to new business models that address varying buyers and influencers, and thereby helps them gain value through improved operational efficiencies. It provides the means to develop a higher level of personalization and change the control points of interaction with targeted endpoints (patient, physician, pharmacy).